Cytochrome c oxidase subunit II

Cytochrome c oxidase subunit II (COXII) is an essential component of cytochrome c oxidase (complex IV), which is the terminal enzyme of the mitochondrial electron transport chain. This subunit plays a pivotal role in the generation of adenosine triphosphate (ATP) through oxidative phosphorylation. COXII, encoded by the mitochondrial genome in most eukaryotes, is integral to the process of cellular respiration and energy production in cells.

Structure and Function

Cytochrome c oxidase subunit II is one of the 14 subunits of cytochrome c oxidase, which is located in the mitochondrial membrane. It is involved in the transfer of electrons from cytochrome c to the enzyme, facilitating the reduction of oxygen to water. This process is coupled with the pumping of protons across the mitochondrial membrane, creating a proton gradient that drives the synthesis of ATP by ATP synthase.

The structure of COXII includes several copper centers and heme groups that are essential for its electron transfer activity. Mutations in the gene encoding COXII can lead to disruptions in its structure and function, potentially resulting in mitochondrial diseases and disorders related to impaired energy production.

Genetic Aspects

The gene for cytochrome c oxidase subunit II is located within the mitochondrial DNA (mtDNA), distinguishing it from most other genes, which are found in the nucleus. This localization has implications for the inheritance and expression of mutations affecting COXII. Diseases associated with mutations in the COXII gene are inherited in a matrilineal manner, as mitochondria, and thus mtDNA, are typically inherited from the mother.

Clinical Significance

Alterations in the function of cytochrome c oxidase subunit II can have profound effects on cellular energy metabolism, leading to a variety of clinical manifestations. Conditions associated with COXII dysfunction include mitochondrial myopathies, Leigh syndrome, and other mitochondrial disorders. These conditions can present with a wide range of symptoms, from muscle weakness and neurological deficits to systemic failures affecting multiple organ systems.

Research and Therapeutic Approaches

Research into cytochrome c oxidase subunit II has focused on understanding its role in mitochondrial dysfunction and developing therapeutic strategies to address related diseases. Approaches include gene therapy aimed at correcting mutations in the COXII gene and treatments designed to enhance mitochondrial function or compensate for energy production deficits.

See Also

• Mitochondrial DNA
• Oxidative phosphorylation
• Electron transport chain
• Mitochondrial disease

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian